An Updated Review of Cardiac Devices in Heart Failure

Overview

Journal Ir J Med Sci

Specialty General Medicine

Date 2017 Mar 27

PMID 28343276

Citations 4

Authors

C Murphy

H Zafar

F Sharif

Affiliations

Soon will be listed here.

Abstract

Background: Heart failure has the highest rates of adult hospitalisations, the highest mortality rates and significant costs associated with its care. The cost of heart failure is expected continue to grow on a global scale, with $108 billion spent on heart failure in 2012. Mortality rates are high, with incident cases of heart failure resulting in 30% 1-year mortality, and in hospital mortality of acute heart failure, 28%.

Methods And Results: This article reviews the devices currently in use for the treatment of heart failure, as well as those that are under investigation. A review of the mechanism of action of devices, the literature supporting their application as therapy, and the cost effectiveness associated with their use are discussed. Conventional techniques discussed herein include the guideline-supported therapies of mechanical circulatory support (MCS) and cardiac resynchronisation therapy (CRT). Novel devices that are discussed include invasive physiological monitoring, neuromodulation, percutaneous ventricular assist devices (VADs) and cardiac contractility modulation (CCM). There has been advancement in mechanical circulatory support devices for the treatment of both acute and chronic heart failure. In addition to MCS, only CRT has resulted in reduced mortality.

Conclusion: Due to the clinical and economic arguments, treatment of heart failure is said to be the biggest unmet need in cardiology today. The data reviewed herein support this statement.

Citing Articles

Comparative effectiveness of mesenchymal stem cell versus bone-marrow mononuclear cell transplantation in heart failure: a meta-analysis of randomized controlled trials.

Hosseinpour A, Kamalpour J, Dehdari Ebrahimi N, Mirhosseini S, Sadeghi A, Kavousi S Stem Cell Res Ther. 2024; 15(1):202.

PMID: 38971816 PMC: 11227704. DOI: 10.1186/s13287-024-03829-7.

Short-term study of atrial shunt and improvement of functional mitral regurgitation.

Shang X, Liu M, Zhong Y, Wang X, Chen S, Fu X J Cardiothorac Surg. 2023; 18(1):332.

PMID: 37968674 PMC: 10648378. DOI: 10.1186/s13019-023-02398-9.

Trends and Challenges in the Development of 3D-Printed Heart Valves and Other Cardiac Implants: A Review of Current Advances.

Bhandari S, Yadav V, Ishaq A, Sanipini S, Ekhator C, Khleif R Cureus. 2023; 15(8):e43204.

PMID: 37565179 PMC: 10411854. DOI: 10.7759/cureus.43204.

Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure.

Ansari U, Overhoff D, Burkhoff D, Fastner C, Yucel G, Roger S Sci Rep. 2022; 12(1):20504.

PMID: 36443407 PMC: 9705404. DOI: 10.1038/s41598-022-24461-6.

References

Yturralde R, Gaasch W . Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis. 2005; 47(5):314-9. DOI: 10.1016/j.pcad.2005.02.007. View

Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O . 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm.... Europace. 2013; 15(8):1070-118. DOI: 10.1093/europace/eut206. View

Macintyre K, Capewell S, Stewart S, Chalmers J, Boyd J, Finlayson A . Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000; 102(10):1126-31. DOI: 10.1161/01.cir.102.10.1126. View

Amat-Santos I, Bergeron S, Bernier M, Allende R, Barbosa Ribeiro H, Urena M . Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device. EuroIntervention. 2014; 10(9):1127-31. PMC: 4390993. DOI: 10.4244/EIJY14M05_07. View

Magalski A, Adamson P, Gadler F, Boehm M, Steinhaus D, Reynolds D . Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002; 8(2):63-70. DOI: 10.1054/jcaf.2002.32373. View

Georgakopoulos D, Little W, Abraham W, Weaver F, Zile M . Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail. 2011; 17(2):167-78. DOI: 10.1016/j.cardfail.2010.09.004. View

Aaronson K, Slaughter M, Miller L, McGee E, Cotts W, Acker M . Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012; 125(25):3191-200. DOI: 10.1161/CIRCULATIONAHA.111.058412. View

Kuck K, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F . New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace. 2013; 16(1):109-28. DOI: 10.1093/europace/eut311. View

Brandt M, Madershahian N, Velden R, Hoppe U . Baroreflex activation as a novel therapeutic strategy for diastolic heart failure. Clin Res Cardiol. 2010; 100(3):249-51. DOI: 10.1007/s00392-010-0249-0. View

10.

Kirkpatrick J, Wieselthaler G, Strueber M, St John Sutton M, Rame J . Ventricular assist devices for treatment of acute heart failure and chronic heart failure. Heart. 2015; 101(14):1091-6. DOI: 10.1136/heartjnl-2014-306789. View

11.

Kuck K, Cappato R, Siebels J, Ruppel R . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102(7):748-54. DOI: 10.1161/01.cir.102.7.748. View

12.

Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H . Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010; 121(9):1086-95. DOI: 10.1161/CIRCULATIONAHA.108.800490. View

13.

Cheng J, den Uil C, Hoeks S, van der Ent M, Jewbali L, van Domburg R . Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30(17):2102-8. DOI: 10.1093/eurheartj/ehp292. View

14.

Abraham W, Adamson P, Bourge R, Aaron M, Costanzo M, Stevenson L . Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011; 377(9766):658-66. DOI: 10.1016/S0140-6736(11)60101-3. View

15.

Kirklin J, Naftel D, Kormos R, Stevenson L, Pagani F, Miller M . Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011; 30(2):115-23. DOI: 10.1016/j.healun.2010.12.001. View

16.

Del Trigo M, Bergeron S, Bernier M, Amat-Santos I, Puri R, Campelo-Parada F . Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study. Lancet. 2016; 387(10025):1290-7. DOI: 10.1016/S0140-6736(16)00585-7. View

17.

Domanski M, Krause-Steinrauf H, Massie B, Deedwania P, Follmann D, Kovar D . A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003; 9(5):354-63. DOI: 10.1054/s1071-9164(03)00133-7. View

18.

Gilotra N, Stevens G . Temporary mechanical circulatory support: a review of the options, indications, and outcomes. Clin Med Insights Cardiol. 2015; 8(Suppl 1):75-85. PMC: 4317108. DOI: 10.4137/CMC.S15718. View

19.

Kwong J, Yu C . Ultrafiltration for acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2014; 172(2):395-402. DOI: 10.1016/j.ijcard.2014.01.069. View

20.

Yu C, Wang L, Chau E, Chan R, Kong S, Tang M . Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005; 112(6):841-8. DOI: 10.1161/CIRCULATIONAHA.104.492207. View